Circulating cell-free <i>BRAF</i> V600E during chemotherapy is associated with prognosis of children with Langerhans cell histiocytosis
Lei Cui, Li Zhang, Honghao Ma, Chanjuan Wang, Dong Wang, Hongyun Lian, Weijing Li, Qing Zhang, Na Li, Tianyou Wang, Zhigang Li, Rui Zhang
Abstract
Circulating cell-free BRAF V600E during chemotherapy is associated with prognosis of children with Langerhans cell histiocytosis *For 71 evaluable patients.
Topics & Concepts
Langerhans cell histiocytosisChemotherapyMedicineCancer researchInternal medicineImmunologyDiseaseHistiocytic Disorders and TreatmentsInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisVascular Malformations and Hemangiomas